Advertisement Promega establishes new cGMP plant - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Promega establishes new cGMP plant

Promega has established a current good manufacturing practice (cGMP) plant to support the US Food and Drug Administration-regulated molecular biology products.

The company expects to recruit around 100 people in this 260,000sq² facility which will be engaged in manufacturing with both committed (fixed) production lines and flexible manufacturing areas.

The building will also have a customer experience center for employees and guests that will include spaces for training, laboratory demonstrations, conferences, an exercise and fitness center and dining.

Promega CEO Bill Linton said this building is our next step in expanding their product supply capabilities worldwide.